Hyaluronic acid Completed Phase 3 Trials for Dry Eye Syndrome (DES) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00599716Safety and Efficacy Assessment of VismedĀ® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome
NCT01382225Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome